Cografted Wharton’s Jelly Cells-derived Neurospheres and BDNF Promote Functional Recovery After Rat Spinal Cord Transection
- 300 Downloads
An animal model of transected spinal cord injury (SCI) was used to test the hypothesis that cografted human umbilical mesenchymal stem cells-derived neurospheres (HUMSC-NSs) and BDNF can promote morphologic and functional recoveries of injured spinal cord. In vitro, HUMSC-NSs terminally differentiated into higher percentages of cells expressing neuronal markers: β-tubulin III and MAP2ab by the supplement with BDNF. Following grafted into injured spinal cord, very few grafted cells survived in the HUMSC-NSs + BDNF-treated (<3%) and HUMSC-NSs-treated (<1%) groups. The survived cells were differentiated into various cells, which were confirmed by double staining of BrdU and neural or glia markers. In comparison, more grafted cells in the HUMSC-NSs + BDNF group transformed into mature neural-like cells, while more grafted cells in the HUMSC-NSs group transformed into oligodendrocyte-like cells. HUMSC-NSs + BDNF-treated group had more greatly improved BBB scores, compared with HUMSC-NSs-treated and medium-treated groups. Additionally, axonal regeneration showed significant improvement in rats receiving HUMSC-NSs + BDNF, compared with HUMSC-NSs-treated and medium-treated groups, as demonstrated by the NF-200-positive staining and Fluorogold (FG) retrograde tracing study. Lastly, a significant reduction in the percentage cavitation was seen in the two cell-treated groups compared with medium control group. These results means BDNF could promote the neural differentiation of HUMSC-NSs in vitro and in vivo. However, cellular replacement is unlikely to explain the improvement in functional outcome. The functional recovery might more rely on the axonal regeneration and neuroprotective action that active by the grafted cells. Cografted HUMSCs and BDNF is a potential therapy for SCI.
KeywordsWharton’s jelly cells Umbilical mesenchymal stem cells BDNF Transplantation Spinal cord injury
We thank Health & Biotech (Guangdong, Guangzhou, China) for them kindly present human umbilical mesenchymal stem cells. This research was supported by Natural Science Found of China (NSFC) (U0632008, 30772232, 30801184), Foundations for Key Sci-Tech Research Projects of Guangdong Province [2006Z3-E522, YUE KEJIBAN (2007) 05/06-7005206, 05/06-7005213,YUECAIJIAO (2008) 258-2008A030201019], and Foundations for Key Sci-Tech Research Projects of Guangzhou [YUEKETIAOZI (2008)3-2008A1-E4011-6].
- 5.Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC et al (2006) Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24(1):115–124. doi: 10.1634/stemcells.2005-0053 PubMedCrossRefGoogle Scholar
- 8.Kwon BK, Liu J, Lam C, Plunet W, Oschipok LW, Hauswirth W et al (2007) Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury. Spine 32(11):1164–1173. doi: 10.1097/BRS.0b013e318053ec35 PubMedCrossRefGoogle Scholar
- 9.Shumsky JS, Tobias CA, Tumolo M, Long WD, Giszter SF, Murray M (2003) Delayed transplantation of fibroblasts genetically modified to secrete BDNF and NT-3 into a spinal cord injury site is associated with limited recovery of function. Exp Neurol 184(1):114–130. doi: 10.1016/S0014-4886(03)00398-4 PubMedCrossRefGoogle Scholar
- 13.Basso DM, Beattie MS, Bresnahan JC, Anderson DK, Faden AI, Gruner JA et al (1996) MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter animal spinal cord injury study. J Neurotrauma 13(7):343–359. doi: 10.1089/neu.1996.13.343 PubMedCrossRefGoogle Scholar
- 21.Mahmood A, Lu D, Wang L, Chopp M (2002) Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma 19(12):1609–1617. doi: 10.1089/089771502762300265 PubMedCrossRefGoogle Scholar